625 Immune priming IFx-Hu2.0 promotes antibody responses necessary for anti-PD1 responses in PD-1 refractory melanoma patients

• Joseph Markowitz,
• Shari Pilon-Thomas,
• Amod A Sarnaik,
• Pei-ling Chen,
• Ahmad A Tarhini,
• Zeynep Eroglu,
• Andrew S Brohl,
• Nikhil I Khushalani,
• Vernon K Sondak,
• Youngchul Kim,
• Michael Shamblott,
• Christopher W Dukes,
• Alejandra Chamizo,
• Marina Bastawrous,
• Edward Garcia,
• Ashraf Delhawi,
• Deanryan BDe Aquino,
• Patricia Lawman

Affiliations

Joseph Markowitz

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Shari Pilon-Thomas

6H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Amod A Sarnaik

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Pei-ling Chen

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Ahmad A Tarhini

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Zeynep Eroglu

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Andrew S Brohl

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Nikhil I Khushalani

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Vernon K Sondak

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Youngchul Kim

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Michael Shamblott

2Morphogenesis, Inc., Tampa, FL, USA

Christopher W Dukes

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Alejandra Chamizo

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Marina Bastawrous

2Morphogenesis, Inc., Tampa, FL, USA

Edward Garcia

2Morphogenesis, Inc., Tampa, FL, USA

Ashraf Delhawi

2Morphogenesis, Inc., Tampa, FL, USA

Deanryan BDe Aquino

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Patricia Lawman

2Morphogenesis, Inc., Tampa, FL, USA